Vor Biopharma Inc. (VOR) NASDAQ
$4.22 0.33 (8.48%)
Market Cap: $158.30M
As of 05/27/22 04:00 PM EDT. Market closed.

Vor Biopharma Inc. (VOR) NASDAQ
$4.22 0.33 (8.48%)
Market Cap: $158.30M
As of 05/27/22 04:00 PM EDT. Market closed.
Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to ... read more
Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
5AM Ventures VI, L.P. | 10% Owner | Nov 16, 2021 | Sale | $15.30 | 330,706 | 5,059,802 | 4,595,089 | Nov 18, 2021, 08:14 PM |
PARMAR KUSH | Director | Nov 16, 2021 | Sale | $15.30 | 330,706 | 5,059,802 | 4,595,089 | Nov 18, 2021, 08:10 PM |
Chakraborty Tirtha | Chief Scientific Officer | Aug 17, 2021 | Option Exercise | $1.36 | 17,446 | 23,727 | 20,980 | Aug 19, 2021, 04:02 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Feb 09, 2021 | Buy | $18.00 | 2,979,566 | 53,632,188 | 8,297,265 | Feb 09, 2021, 06:25 PM |
5AM Ventures VI, L.P. | 10% Owner | Feb 09, 2021 | Buy | $18.00 | 555,555 | 9,999,990 | 4,833,959 | Feb 09, 2021, 06:03 PM |
PARMAR KUSH | Director | Feb 09, 2021 | Buy | $18.00 | 555,555 | 9,999,990 | 4,833,959 | Feb 09, 2021, 05:15 PM |
Owner | Relationship | Date | Value($) |
5AM Ventures VI, L.P. | 10% Owner | 11/16/2021 | 5,059,802 |
PARMAR KUSH | Director | 11/16/2021 | 5,059,802 |
Chakraborty Tirtha | Chief Scientific Officer | 08/17/2021 | 23,727 |
RA CAPITAL MANAGEMENT, L.P. | Director | 02/09/2021 | 53,632,188 |
5AM Ventures VI, L.P. | 10% Owner | 02/09/2021 | 9,999,990 |
PARMAR KUSH | Director | 02/09/2021 | 9,999,990 |